# Nuclide record nct06777433 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06777433/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06777433", "NCT06777433" ;
  schema:name "Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases"@en ;
  schema:description "A phase 2 trial of RAD101 (18F-FPIA) in brain and spinal cord tumours, run by Radiopharm Theranostics, Ltd, active and no longer recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct06777433/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06777433> ;
  nuclide:status "active" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "2" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:companies <https://nuclide.cc/companies/radiopharm-theranostics/> .